You are here: Industry Insights > Omicron

News List

New study finds AstraZeneca booster generates higher antibodies against Omicron pharmatimes
January 13, 2022
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.
U.S. May Soon See Sharp Drop in Omicron Cases, Experts Say drugs.com
January 12, 2022
The omicron surge may have peaked in Britain and could be about to do the same in the United States, experts report.
Nearly 600,000 U.S. Children Had COVID-19 Last Week drugs.com
January 12, 2022
In a sign that the highly contagious omicron variant is sparing no one, a report shows that new COVID-19 cases among U.S. children...
BinaxNOW Test Catches COVID-19 Infection in Many People, Study Shows drugs.com
January 12, 2022
Countering earlier concerns, a real-world study shows that a widely used at-home COVID-19 test called BinaxNOW is as effective at detecting omicron as other coronavirus variants.
Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod prnasia
January 11, 2022
With an increasing number of confirmed cases in Hong Kong, S.A.R., China, S.A.R., China since the initial transmission on 27th December 2021, the recent Omicron outbreak is of utmost concern in the community.
Drugmakers Meet With EMA on Vaccines Targeting Omicron FirstWordPharma
January 11, 2022
The European Medicines Agency (EMA) is meeting with four leading COVID-19 vaccine makers to discuss potential trials for shots targeting the fast-spreading Omicron variant, as reported in the Financial Post.
Omicron wave disrupts wage growth hopes in Australia – leading macroeconomic influencers Pharmaceutical-Technology
January 11, 2022
Some economists believe that the Omicron wave will be a clear risk to pay rises this year, as increasing case numbers threaten to disrupt Australia’s economic recovery.
COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose WorldPharmaNews
January 10, 2022
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months.
Immune Biosolutions Lead Immunotherapy Neutralizes SARS-CoV-2 Variants contractpharma
January 10, 2022
IBIO123 is an inhaled antibody-based immunotherapy in phase 1 and 2 clinical development for the treatment of symptomatic SARS-CoV-2.
FDA Warns Against Using At-Home COVID-19 Test Swabs in the Throat drugs
January 10, 2022
Swabs that come with at-home rapid antigen COVID-19 tests should be used in the nose and not the throat, the U.S. Food and Drug Administration warns.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page